User Guide
1 *** NOT INTENDED FOR COMMERCIAL USE*** Additional Information Available: CISelect.questions@gmail.com ...
Using AI to Predict Immunotherapy Response in Lung Cancer
An NCI grant to NYU Langone’s Perlmutter Cancer Center and Case Western Reserve University will improve immunotherapy for lung cancer.
Using Artificial Intelligence to Identify PTSD
Researchers at NYU Langone, led by psychiatrist Dr. Charles R. Marmar, are harnessing artificial intelligence to make PTSD easier to identify.
Using Behavior Activation to Fight the COVID-19 Blues
NYU Langone’s Dr. Eric Lewandowski offers advice for teens to help cope with depression during the COVID-19 pandemic.
Using Big Data to Connect Medical Education & Patient Care
NYU School of Medicine has analyzed vast data sets to determine how its medical-training curriculum impacts patient outcomes in the real world.
Using Biomarkers to Guide Ovarian Cancer Treatment Decisions
NYU Langone expert Dr. Douglas A. Levine explains how biomarkers can help oncologists predict a person’s response to ovarian cancer treatment.
Using Biomarkers to Target Advanced Lung Cancer Treatment
Dr. Vamsidhar Velcheti, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses using biomarkers to tailor cancer treatment.
Using Biopsies to Diagnose Breast Cancer
Dr. Nancy Chan, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses the importance of biopsies to diagnose breast cancer.
Using Immunotherapy to Treat Advanced Liver Cancers
Dr. Theodore H. Welling, a surgical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses treatments for advanced liver cancers.
Using Targeted Treatments for Advanced Lung Cancer
Dr. Vamsidhar Velcheti, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses targeted treatments for advanced lung cancer.